Skip to main content
Top
Published in: Diabetologia 5/2011

01-05-2011 | Commentary

Risk scores for predicting type 2 diabetes: comparing axes and spades

Authors: N. J. Wareham, S. J. Griffin

Published in: Diabetologia | Issue 5/2011

Login to get access

Excerpt

A recent systematic review of risk prediction tools for identifying individuals at risk for type 2 diabetes identified a total of 46 different studies reporting the derivation of risk models [1]. These scores included diverse types of variables ranging from simple information generally available in health records through to more detailed biochemical and genetic variables. The paper by the Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) group in this issue of Diabetologia reports the results of an evaluation of a modified version of one of the most widely investigated diabetes risk prediction tools, the Finnish Diabetes risk score [2]. In this paper the variables included in the prediction model were age, BMI, waist circumference, use of blood pressure medication and previous high blood glucose defined as history of gestational diabetes. The authors compare the predictive ability of this new score with that of the original Finnish risk score and a number of other models. The DETECT-2 group’s conclusion was that this new model performed better than existing risk scores as assessed by the area under the receiver operating characteristic (ROC) curve. …
Literature
1.
go back to reference Schulze MB, Simmons R, Griffin SG (2011) Risk prediction tools for identifying individuals at risk for type 2 diabetes. Epidemiologic Reviews (in press) Schulze MB, Simmons R, Griffin SG (2011) Risk prediction tools for identifying individuals at risk for type 2 diabetes. Epidemiologic Reviews (in press)
2.
go back to reference Alssema M, Vistisen D, Heymans M et al (2011) The DETECT-2 update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia. doi:10.1007/s00125-010-1990-7 Alssema M, Vistisen D, Heymans M et al (2011) The DETECT-2 update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia. doi:10.​1007/​s00125-010-1990-7
3.
go back to reference Rahman M, Simmons RK, Harding AH, Wareham NJ, Griffin SJ (2008) A simple risk score identifies individuals at high risk of developing type 2 diabetes: a prospective cohort study. Fam Pract 25:191–196PubMedCrossRef Rahman M, Simmons RK, Harding AH, Wareham NJ, Griffin SJ (2008) A simple risk score identifies individuals at high risk of developing type 2 diabetes: a prospective cohort study. Fam Pract 25:191–196PubMedCrossRef
4.
go back to reference Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 338:b880PubMedCrossRef Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 338:b880PubMedCrossRef
5.
go back to reference Stern MP, Fatehi P, Williams K, Haffner SM (2002) Predicting future cardiovascular disease: do we need the oral glucose tolerance test? Diab Care 25:1851–1856CrossRef Stern MP, Fatehi P, Williams K, Haffner SM (2002) Predicting future cardiovascular disease: do we need the oral glucose tolerance test? Diab Care 25:1851–1856CrossRef
6.
go back to reference Meigs JB, Shrader P, Sullivan LM et al (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 359:2208–2219PubMedCrossRef Meigs JB, Shrader P, Sullivan LM et al (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 359:2208–2219PubMedCrossRef
Metadata
Title
Risk scores for predicting type 2 diabetes: comparing axes and spades
Authors
N. J. Wareham
S. J. Griffin
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2101-0

Other articles of this Issue 5/2011

Diabetologia 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine